[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3348 Introduced in House (IH)]

<DOC>






115th CONGRESS
  1st Session
                                H. R. 3348

To expand the tropical disease product priority review voucher program 
   to encourage treatments for the Middle East respiratory syndrome.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 20, 2017

  Mr. Peters (for himself, Mr. Brendan F. Boyle of Pennsylvania, Mr. 
  Marshall, and Mr. Rothfus) introduced the following bill; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To expand the tropical disease product priority review voucher program 
   to encourage treatments for the Middle East respiratory syndrome.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Adding Middle East Respiratory 
Syndrome to the FDA Priority Review Voucher Program Act''.

SEC. 2. EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW VOUCHER 
              PROGRAM TO ENCOURAGE TREATMENTS FOR MIDDLE EAST 
              RESPIRATORY SYNDROME.

    Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 360n(a)(3)) is amended--
            (1) by redesignating subparagraph (S) as subparagraph (T); 
        and
            (2) by inserting after subparagraph (R) the following:
                    ``(S) Middle East respiratory syndrome.''.
                                 <all>